Blood Testing in Menopause: Clinical Diagnosis Takes Priority
In most women entering menopause, no blood tests are needed—the diagnosis is made clinically based on 12 consecutive months of amenorrhea in women over 45 years old with an intact uterus 1, 2.
When Blood Tests Are NOT Indicated
The Endocrine Society explicitly states that sex steroids, gonadotropins, inhibin B, or anti-Müllerian hormone measurements do not further inform the diagnosis, do not indicate precisely when the final menstrual period will occur, and will not influence management unless fertility is being pursued 1. This is because all postmenopausal women are expected to have low sex steroid levels, making such measurements clinically meaningless for diagnosis 3.
Key Point on Salivary Testing
Salivary hormone testing, often promoted for "bioidentical hormone" management, is not approved by the FDA or Clinical Laboratory Improvement Amendments and shows large intrasubject variability that fluctuates with diet, hydration, and circadian rhythm 3. Avoid this testing entirely.
When Blood Tests ARE Indicated
Blood testing becomes useful in specific clinical scenarios where menstrual history cannot establish the diagnosis:
1. Post-Hysterectomy (Ovaries Intact)
- Order: FSH and estradiol on multiple occasions
- Diagnostic criteria: FSH ≥40 mIU/mL combined with estradiol <20 pg/mL, measured at least 3 months post-procedure 1, 2
- These replicate measures provide presumptive (not definitive) diagnosis 1
2. Women on Hormonal Contraception
The guidelines are clear here: hormonal assays are NOT recommended to diagnose menopause in women using oral contraceptives, implants, or levonorgestrel IUDs 2. The recommended approach is:
- Stop oral contraception or remove the device
- Follow clinically for amenorrhea development
- If testing is performed on day 7 of the pill-free interval, FSH <30 mIU/mL is not sensitive (62.5% of menopausal women still had FSH <30) 4
- More useful markers if testing: FSH:LH ratio >1 or estradiol <20 pg/mL 4
3. Inadequate Menstrual History
When vasomotor symptoms are present but menstrual history is unclear:
- Order: Replicate FSH and estradiol measurements 1
- This provides presumptive diagnosis when combined with clinical symptoms
4. Post-Cancer Treatment
After gonadotoxic cancer treatment, the 12-month amenorrhea criterion cannot reliably diagnose menopause, yet no examination can definitively diagnose menopause in this population 2. Consider the patient's pre-treatment menopausal status for therapeutic decisions.
Additional Screening Tests (Not for Diagnosis)
While not diagnostic for menopause itself, comprehensive preventive screening should include 5:
- Lipid panel (cardiovascular risk assessment)
- Thyroid function tests (TSH) to exclude thyroid disorders that can mimic menopausal symptoms 1, 5
- Fasting glucose and HbA1c (diabetes screening, as metabolic changes occur) 6
- Hemoglobin (anemia screening)
- Stool occult blood, Pap smear (cancer screening, not menopause-specific)
Common Pitfalls to Avoid
- Don't order FSH/estradiol in women with clear clinical menopause (12 months amenorrhea, age >45)—it adds no value and wastes resources
- Don't rely on single FSH measurements—hormone levels fluctuate during perimenopause
- Don't use hormone levels to "individualize" or "optimize" hormone therapy dosing—this approach lacks evidence and standardization 3
- Don't delay appropriate symptom management waiting for laboratory confirmation when clinical diagnosis is clear
The evidence consistently demonstrates that menopause remains fundamentally a clinical diagnosis requiring laboratory confirmation only in specific circumstances where clinical criteria cannot be applied.